NCT01710137View on ClinicalTrials.gov

Varenicline for Nicotine Dependence Among Those With HIV/AIDS

PHASE3CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Nicotine Dependence
Interventions
DRUG

Varenicline

DRUG

Placebo

BEHAVIORAL

Smoking Cessation Counseling

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT01710137 - Varenicline for Nicotine Dependence Among Those With HIV/AIDS | Biotech Hunter | Biotech Hunter